Archives

Scrip’s John Davis wrote an article on Amphera:

https://scrip.pharmaintelligence.informa.com/SC124930/Amphera-Gears-Up-To-Evaluate-Dendritic-Cells-For-Pleural-Mesothelioma

Nuala Moran of BioWorld covered Amphera’s press release as well:

http://www.bioworld.com/content/amphera-taking-mesothelioma-dendritic-cell-vaccine

On January 25, 2018 National and regional newspapers in The Netherlands published an article on the MESOPEC study. Investigator dr. Eva Madsen and a patient are interviewed. MESOPEC is a phase II study with MesoPher in peritoneal mesothelioma.

The article (in Dutch) can be found on: https://www.ad.nl/wetenschap/veelbelovende-behandelmethode-tegen-asbestkanker~a900b9dc/

Amphera is happy to announce that the results of our phase I/II study with MesoPher in mesothelioma are published in the February 2018 issue of Clinical Cancer Research.